Home › Medivir Announces That Janssen Has Started a Phase IIa Study to...
 

Keywords :   


Medivir Announces That Janssen Has Started a Phase IIa Study to...

2015-10-16 18:07:48| Appliances - Topix.net

Medivir AB today announces that Alios BioPharma Inc., part of the Janssen Pharmaceutical Companies , has started a phase IIa clinical trial to evaluate the combination of simeprevir, odalasvir , and AL-335 in treatment-nai 1 2ve patients with genotype 1 chronic hepatitis C virus infection. This phase IIa study is a randomized, open-label, three-arm study of AL-335, a nucleotide-based HCV NS5B polymerase inhibitor, odalasvir, an HCV NS5A inhibitor and simeprevir, an HCV NS3/4A protease inhibitor.

Tags: to study started phase

Category:Consumer Goods and Services

Latest from this category

All news
15.11Bitcoin hacker sentenced to five years in prison
15.11Europe's flying taxi dreams falter as cash runs short
14.11UK must rebuild post-Brexit relations with EU, says Bank boss
14.11The Onion buys Alex Jones's Infowars at auction
14.11Meta fined 798m over 'unfair' Facebook Marketplace
14.11Meta fined 798m over 'unfair' Facebook Marketplace
14.11Amazon launches Temu and Shein rival with 'crazy low' prices
14.11Amazon launches Temu and Shein rival with 'crazy low' prices
Consumer Goods and Services »
15.112
15.11
15.11 RIDE THE 92 23-24
15.11
15.114m×4m
15.11FG/AG 25.0
15.11
15.11Edwards
More »